Sector Firms vs Generalists: Who Tops Deal Lists by Industry, 2026

Ask which law firms advise on the most deals by industry and the answer changes with the sector. Sartori & Partners data show 48,131 dated deals in the 12 months to October 2026, advised by 1,134 firms. Latham & Watkins heads the all-industry list in the 1,200+ band. Split the same deals by client industry and the picture breaks up. The generalist keeps first place in oil and gas, but in healthcare providers and payors, in pharma and biotech, and in technology and software, a firm built around the sector comes first. For a firm that competes in one of those sectors, the rival to measure against is often not the name at the top of the overall table.

Two reading notes. Deal counts are matters on record, including disputes taken from public court records, so a band measures volume of work, not revenue. Firm hiring ranks count lawyers hired one by one; a team that joined in the same quarter is in the market totals but not in a firm's rank.

Latham & Watkins heads the oil and gas adviser list in the 151-250 band, one band above Vinson & Elkins in 101-150. Kirkland & Ellis is third and Baker Botts fifth. The sector is small for the leader: oil and gas clients made up about 5% of the deals Latham & Watkins advised, against about 10% each for pharma and biotech and for technology and software. It wins first place in oil and gas with a slice of its book.

The work is capital markets heavy and anchored in one city. Capital markets deals were 40.2% of oil and gas deals, against 25.7% across all industries, and lawyers in Houston worked on 48.2% of them. Oil and gas deal volume was flat on settled windows, 1,012 deals against 961 a year earlier (+5.3%).

For an energy firm, this is the hardest sector to win on volume. The leader carries the issuer and underwriter relationships of a firm that heads every industry combined. Competing means owning the Houston bench and the regulatory and project work where scale counts for less.

The healthcare provider and payor list looks nothing like the overall table. Bass, Berry & Sims sits alone in the 101-150 band. Latham & Watkins is 3rd, sharing the 21-40 band with four other firms. Bass, Berry & Sims is a firm of 400-999 lawyers that ranks in the 26-50 group by deals across all industries, yet no firm advises more hospitals and health plans.

The concentration runs both ways. Healthcare providers and payors were about 35% of the firm's own deals, its largest client industry by a wide margin, and about 55% of its 12-month lateral hires joined in Nashville. In the Sartori & Partners deal records, lawyers in Nashville worked on 12.4% of the sector's deals, more than lawyers in Boston or London.

The sector is growing. Healthcare provider and payor deals rose 13.4% on settled windows, 1,084 against 956, ahead of the whole deal market, which rose 10.6%. Disputes and investigations made up 39.2% of the sector's deals, so litigation volume counts on this list as much as transactions. A firm entering this sector meets a specialist several bands clear of the field, with a Nashville base that the generalists on the list do not match.

Pharma and biotech is a larger market, with 3,276 deals in 12 months against 1,110 for healthcare providers. Cooley and Goodwin Procter share the 251-400 band at the top. Latham & Watkins is 3rd in the 151-250 band, level with Wilson Sonsini Goodrich & Rosati.

Capital markets work explains much of the order. Capital markets deals were 52.4% of pharma and biotech deals, about 2.0 times their share across all industries. Venture and growth financings add 6.0%. Firms that follow companies from early rounds to public offerings collect the volume. Pharma and biotech deals rose 14.5% year on year on settled windows, 3,298 against 2,880.

The bench sits in Boston. Lawyers in Boston worked on 25.5% of pharma and biotech deals, and Boston took 18.6% of lateral moves by lawyers focused on the sector, an index of 718 against the market. A firm building a life sciences practice is bidding against the two firms at the top for the same Boston capital markets and venture lawyers.

Wilson Sonsini Goodrich & Rosati heads the technology and software list. The lead is narrow: Latham & Watkins and Davis Polk & Wardwell sit in the same 151-250 band. Cooley, first in pharma, is 6th here.

Technology deals were flat on settled windows, 3,279 against 3,136 (+4.6%). Lateral hiring among technology-focused lawyers rose 18.3% over the same windows, and San Francisco took 17.9% of those moves. Venture and growth deals were 15.3% of technology deals, against 3.8% across all industries.

Here a sector firm and the generalist meet on equal volume. With deal flow steady and hiring rising, a technology firm should expect to compete for the same San Francisco lawyers against both kinds of rival at once.

Bass, Berry & Sims heads the health care lateral hiring list in the 11-20 band, the same firm that heads the healthcare provider deal list. Across all practices it ranks in the 101-200 group of hirers; the sector is where it concentrates. Health care was about 45% of its 12-month lateral hires, and partners about 25%. Net partner flow, lateral partners hired against partners who left for another firm over 12 months, was positive.

The other deal leaders hire elsewhere. Of the healthcare provider deal top 10, only Bass, Berry & Sims and King & Spalding appear on the health care hiring top 10, where 7th is the latter's place. The rest of the hiring list, from Polsinelli to Barnes & Thornburg, carries no top-10 healthcare provider deal rank.

The pool is growing. Sartori & Partners data show health care lateral moves rose 14.5% on settled windows, 434 against 379. Firms of 1,000+ lawyers took 48.5% of those moves, so the deal and hiring leader, a firm of 400-999 lawyers, recruits against larger firms that do not lead the sector's deal list. For a firm hiring health care partners, that means the rival with the strongest deal story is also in the room for candidates.

First, benchmark against the sector list, not the overall one. Latham & Watkins is first overall and in oil and gas, but it is 3rd for healthcare providers, 3rd in pharma and biotech and 2nd in technology. A firm in those sectors faces a specialist at the top.

Second, in healthcare providers, plan for one rival that leads on both fronts. The firm first by deals is first by health care hires, and its hires concentrate in Nashville. A firm hiring there should move quickly and expect a counter-offer built on deal flow.

Third, in pharma and in technology, the top band is shared, so no single rival sets the price. Recruit in Boston for life sciences capital markets and in San Francisco for technology, and expect both the sector firms and the generalist in each search.

Fourth, in oil and gas, competing on volume with the all-industry leader is a long game. Build where the sector's work is done, in Houston, and in the regulatory, project and disputes work where a smaller bench can still lead.